TipRanks
Buda Juice, Inc. (BUDA)
:BUDA
US Market
Want to see BUDA full AI Analyst Report?

Buda Juice, Inc. (BUDA) AI Stock Analysis

3 Followers

Top Page

BUDA

Buda Juice, Inc.

(BUDA)

Select Model
Select Model
Select Model
Neutral 69 (OpenAI - Gpt-5.6Sol)
Rating:69Neutral
Price Target:
$7.50
▼(-10.39% Downside)
Action:N/A
Date:10/17/26
BUDA scores as a solid but not top-tier setup: strong profitability and rapid revenue growth (with generally healthy cash generation and improved 2025 balance-sheet conservatism) drive the score. Offsetting that strength are weakening near-term technicals (below key moving averages with negative MACD) and a demanding valuation (P/E ~39), along with some 2025 margin/cash-flow softness to monitor.
Positive Factors
Exceptional Revenue Growth
Revenue growth of approximately 98.5% indicates strong expansion in the company’s sales base and market reach. If this pace remains supported by underlying demand, it can provide operating leverage, fund reinvestment, and strengthen Buda Juice’s competitive position over the next several quarters.
Negative Factors
Earnings Scaling Pressure
Net income declining slightly while revenue nearly doubled suggests that incremental sales are not converting into earnings at the same rate. Possible margin pressure or higher operating costs could limit operating leverage and make future growth less valuable if the pattern persists.
Read all positive and negative factors
Positive Factors
Negative Factors
Exceptional Revenue Growth
Revenue growth of approximately 98.5% indicates strong expansion in the company’s sales base and market reach. If this pace remains supported by underlying demand, it can provide operating leverage, fund reinvestment, and strengthen Buda Juice’s competitive position over the next several quarters.
Read all positive factors

Buda Juice, Inc. (BUDA) vs. SPDR S&P 500 ETF (SPY)

Buda Juice, Inc. Business Overview & Revenue Model

Company Description
Established in 2013, Buda Juice is a Dallas, Texas-based enterprise specializing in the creation and distribution of organic, cold-pressed beverages. The company's offerings, all USDA-certified organic and crafted from fresh fruits and vegetables,...

Buda Juice, Inc. Financial Statement Overview

Summary
Strong income statement quality (high gross and net margins and very strong 2025 revenue growth) and solid cash generation support a high score. This is tempered by signs of scaling pressure (2025 net income slightly below 2024) and softer cash conversion in 2025 (free cash flow and operating cash flow down versus 2024), plus notable year-to-year balance sheet leverage shifts that warrant monitoring.
Income Statement
86
Very Positive
Balance Sheet
78
Positive
Cash Flow
74
Positive
BreakdownTTMDec 2025Dec 2024Dec 2023
Income Statement
Total Revenue14.08M12.61M11.27M9.38M
Gross Profit5.52M5.39M5.21M3.80M
EBITDA3.00M3.90M4.04M2.71M
Net Income2.41M3.53M3.57M2.26M
Balance Sheet
Total Assets23.81M4.97M3.73M2.96M
Cash, Cash Equivalents and Short-Term Investments18.82M1.84M1.89M1.43M
Total Debt717.00K782.00K68.00K2.19M
Total Liabilities2.17M1.23M575.00K2.56M
Stockholders Equity21.64M3.74M3.16M401.00K
Cash Flow
Free Cash Flow1.59M2.90M3.29M1.97M
Operating Cash Flow2.26M3.15M3.97M2.23M
Investing Cash Flow-764.00K-246.00K-684.00K-249.00K
Financing Cash Flow15.62M-2.95M-2.83M-1.39M

Buda Juice, Inc. Risk Analysis

Buda Juice, Inc. disclosed 41 risk factors in its most recent earnings report. Buda Juice, Inc. reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Buda Juice, Inc. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (55)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
69
Neutral
$82.94M34.4519.22%―――
55
Neutral
$6.65B3.83-15.92%6.20%10.91%7.18%
44
Neutral
$5.89M-0.96-845.37%―0.32%-550.93%
30
Underperform
$259.68K>-0.01639.85%―3.17%-184.54%
* General Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
BUDA
Buda Juice, Inc.
6.60
-1.51
-18.62%
BLIV
BeLive Holdings
2.29
-1.31
-36.39%
DLXY
Delixy Holdings Limited
1.80
-2.74
-60.35%
AGCC
Agencia Comercial Spirits Ltd. Class A
15.10
10.62
237.05%
MEHA
Functional Brands Inc
0.02
-1.28
-98.46%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 17, 2026